Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 17, Issue 8, 2005, Pages 1022-1029

  Haug, Nancy A ^a,b   Sorensen, J L ^a,b   Lollo, N D ^b   Gruber, V A ^a,b   Delucchi, K L ^a   Hall, S M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE DERIVATIVE; ANTIRETROVIRUS AGENT; BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; DIAMORPHINE; METHADONE; OPIATE; VIRUS RNA;

ADULT; ANOREXIA; ARTHRALGIA; ARTICLE; BECK DEPRESSION INVENTORY; BLOATING; CHILL; COCAINE DEPENDENCE; CONTROLLED STUDY; COUGHING; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRY SKIN; DYSURIA; EMOTION; FATIGUE; FEMALE; FEVER; FOLLOW UP; HEADACHE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAUNDICE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; METHADONE TREATMENT; MYALGIA; NAUSEA; OUTPATIENT; PAIN; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RASH; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SHORT FORM 36; TREATMENT OUTCOME; VOMITING;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HIV INFECTIONS; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTICS; PATIENT COMPLIANCE; SEX FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 27144542395     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540120500100882     Document Type: Article

References (22)

1. Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C., et al. (2001). Antiretroviral therapy adherence in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, 1417-1423.
2. Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., et al. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17, 377-381.
3. Avants, S. K., Margolin, A., Warbourton, L. A., Hawkins, K. A., & Shi, J. (2001). Predictors of nonadherence to HIV-related medication regimens during methadone stabilization. American Journal of Addictions, 10, 69-78.
4. Beck, A. T., Steer, R. A., & Brown, G. K. (1996). BDI-II manual. San Antonio, TX: The Psychological Corporation.
5. Center for Disease Control and Prevention (2002). Cases of HIV infection and AIDS in the United States, 2002. HIV/AIDS Surveillance Report, 14, 1-48.
6. Chesney, M. (2003). Adherence to HAART regimens. AIDS Patient Care and STDs, 17, 169-177.
7. Chesney, M. A., Ickovics, J. R., Chamber, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. AIDS Care, 12, 255-266.
8. Howard, A. A., Arnsten, J. H., Yungtai, L., Vlahov, D., Rich, J. D., Schuman, P., et al. (2002). A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS, 16, 2175-2182.
9. Johnston Roberts, K., & Mann, T. (2000). Barriers to antiretroviral medication adherence in HIV-infected women. AIDS Care, 12, 377-386.
10. Lucas, G. M., Chaisson, R. E., & Moore, R. D. (1999). Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Annals of Internal Medicine, 131, 81-87.
11. Lucas, G. M., Cheever, L. W., Chaisson, R. E., & Moore, R. D. (2001). Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. Journal of Acquired Immune Deficiency Syndrome, 27, 251-259.
12. Marascuilo, L. A., & McSweeny, M. (1977). Nonparametric and distribution-free methods for the social sciences. Monterey, CA: Brooks/Cole.
13. McCance-Katz, E. F., Rainey, P. M., Smith, P., Morse, G., Friedland, G., Gourevitch, M., et al. (2004). Drug interactions between opioids and antiretroviral medications: Interaction between methadone, LAAM and nelfinavir. The American Journal on Addictions, 13, 163-180.
14. McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., et al. (1992). The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment, 9, 199-213.
15. Moss, A. R., Hahn, J. A., Perry, S., Charlebois, E. D., Guzman, D., Clark, R. A., et al. (2004). Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: A prospective study. Clinical Infectious Diseases, 39, 1190-1198.
16. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
17. Robins, L., Cottler, L., Bucholz, K., & Compton, W. (1995). Diagnostic Interview Schedule for DSM-IV (DIS-IV) . St. Louis, MO: Department of Psychiatry, Washington University School of Medicine.
18. Schuman, P., Ohmit, S. E., Cohen, M., Sacks, H. S., Richardson, J., Young, M., et al. (2001). Prescription of and adherence to antiretroviral therapy among women with AIDS. AIDS and Behavior, 5, 371-378.
19. Sorensen, J. L., Haug, N. A., Delucchi, K., Gruber, V., Tulsky, J. P., Hall, S. M., et al. (2004). Voucher reinforcement trial to improve methadone treatment for injection drug users with HIV infection. Paper presented at the College on Problems of Drug Dependence Sixty-sixth Annual Scientific Meeting, San Juan, Puerto Rico.
20. Turner, B. J., Laine, C., Cosle, L., & Hauck, W. W. (2003). Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. Journal General Internal Medicine, 18, 248-257.
21. Wagner, G. J., Kanouse, D. E., Koegel, P., & Sullivan, G. (2003). Adherence to HIV antiretrovirals among persons with serious mental illness. AIDS Patient Care and STDs, 17, 179-186.
22. Ware, J. E. (1996). The MOS 36-Item Short-Form Health Survey (SF-36). In L.I. Sederer, & B. Dickey (Eds.), Outcomes assessment in clinical practice. Baltimore, MD: Williams and Wilkins.